Pangaea Oncology Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	0.57	1.38	7.1	2.02	0.25	0.34
Short-Term Investments	1.29	1.41	1.41	0.91	0.93	1.19
Cash & Short-Term Investments	1.86	2.79	8.51	2.93	1.18	1.52
Cash Growth	-63.31%	-67.22%	190.44%	149.16%	-22.83%	-16.72%
Accounts Receivable	5.3	5.67	3.66	3.6	2.84	2.11
Other Receivables	0.34	0.63	0.73	0.49	1.03	1.2
Receivables	5.65	6.3	4.38	4.08	3.87	3.31
Inventory	0.64	0.54	0.41	0.51	0.47	0.29
Other Current Assets	0.2	-	-	-	-0	-
Total Current Assets	8.35	9.63	13.31	7.52	5.52	5.13
Property, Plant & Equipment	0.61	0.55	0.35	0.43	0.55	0.64
Long-Term Investments	0	0	0.49	0.57	0.12	0.04
Goodwill	3.07	3.22	0.55	-10.59	0	0
Other Intangible Assets	2.96	3.51	1.39	3.72	1.73	2
Long-Term Deferred Tax Assets	2.7	2.69	3.98	4.01	3.79	4.01
Long-Term Deferred Charges	9.13	9.18	8.25	15.14	5.23	5.06
Other Long-Term Assets	0.05	0.05	0.05	0.04	0.04	-
Total Assets	26.87	28.83	28.38	20.85	16.98	16.88
Accounts Payable	2.14	2.33	0.86	0.74	1.16	0.98
Accrued Expenses	0.77	0.44	0.13	0.13	0.12	0.1
Short-Term Debt	-	0.09	-	-	-	1.99
Current Portion of Long-Term Debt	3.19	2.61	1.21	1.62	2.14	0.88
Current Income Taxes Payable	0.06	0.06	-	-	-	-
Other Current Liabilities	1.08	1.65	0.52	0.7	1.21	1.05
Total Current Liabilities	7.23	7.17	2.72	3.18	4.64	5.01
Long-Term Debt	0.71	0.68	1.23	1.93	2.19	0.85
Long-Term Deferred Tax Liabilities	0.92	0.99	0.29	0.31	0.24	0.27
Other Long-Term Liabilities	1.09	1.18	1.06	1.34	1.61	2.44
Total Liabilities	9.95	10.03	5.3	6.76	8.68	8.56
Common Stock	0.61	0.61	0.61	0.45	0.37	0.34
Additional Paid-In Capital	28.51	28.51	28.51	16.31	11.06	19.77
Retained Earnings	-13.46	-11.83	-7.85	-4.49	-3.7	-12.76
Treasury Stock	-0.11	-0.45	-0.07	-0.09	-0.18	-
Comprehensive Income & Other	0.74	0.99	1.7	1.91	0.75	0.96
Total Common Equity	16.28	17.82	22.89	14.09	8.3	8.31
Minority Interest	0.64	0.98	0.18	-	-	-
Shareholders' Equity	16.92	18.81	23.08	14.09	8.3	8.31
Total Liabilities & Equity	26.87	28.83	28.38	20.85	16.98	16.88
Total Debt	3.9	3.38	2.44	3.55	4.33	3.72
Net Cash (Debt)	-2.04	-0.59	6.08	-0.62	-3.15	-2.2
Net Cash Per Share	-0.07	-0.02	0.20	-0.03	-0.17	-0.13
Filing Date Shares Outstanding	30.43	30.14	30.44	22.53	18.73	16.89
Total Common Shares Outstanding	30.43	30.14	30.44	22.53	18.73	16.89
Working Capital	1.12	2.46	10.58	4.34	0.88	0.12
Book Value Per Share	0.53	0.59	0.75	0.63	0.44	0.49
Tangible Book Value	10.25	11.1	20.95	20.95	6.58	6.31
Tangible Book Value Per Share	0.34	0.37	0.69	0.93	0.35	0.37
Land	-	-	-	-	-	0.07
Buildings	0.15	0.07	0.07	0.07	0.07	-
Machinery	0.6	0.6	0.6	0.59	0.59	2.19

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.